MYRG
MYR Group Inc.
MYRG has the edge over RKLB overall, supported by lower modeled downside and stronger modeled upside.
RKLB
Rocket Lab USA, Inc.
RKLB's outlook is improving, though it still trails on the overall score.
MYRG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Healthy |
MYRG's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
MYRG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $214 | -23% |
| Forward | 19x | $278 | — |
| Current | 23x | $278 | — |
| Fair | 24x | $300 | +7.6% |
| Expensive | 42x | $513 | +84% |
Historical ranges are pointers, not guarantees.
MYRG's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
MYRG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for MYRG, with profitability improving. However, they disagree widely on these estimates.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MYRG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.56 | +18% |
| Q3 2026 | $12.31 | +100% |
| Q2 2026 | $10.54 | +121% |
| Q1 2026 | $9.07 | +320% |
| Q4 2025 | $7.53 | +311% |
| Q3 2025 | $6.17 | +172% |
| Q2 2025 | $4.77 | +64% |
| Q1 2025 | $2.16 | -58% |
| Q4 2024 | $1.83 | -66% |
MYRG has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
MYRG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +32% |
| Q2 2026 | $1.1B | +20% |
| Q1 2026 | $1B | +20% |
| Q4 2025 | $973.5M | +17% |
| Q3 2025 | $950.4M | +7% |
| Q2 2025 | $900.3M | +8.6% |
| Q1 2025 | $833.6M | +2.2% |
| Q4 2024 | $829.8M | -17% |
MYRG's revenue has grown year over year for seven quarters in a row: $1.3B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.8% | +1.9 points |
| Q2 2026 | 6.3% | +1.9 points |
| Q1 2026 | 6.5% | +2.4 points |
| Q4 2025 | 4.8% | +1.2 points |
| Q3 2025 | 4.9% | +2.6 points |
| Q2 2025 | 4.4% | +6.9 points |
| Q1 2025 | 4.1% | +1.1 points |
| Q4 2024 | 3.6% | -0.1 points |
MYRG has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over MYRG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
MYRG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9.2M | -86% |
| Q2 2026 | -$25.6M | -320% |
| Q1 2026 | $68.6M | -2.3% |
| Q4 2025 | $84.9M | +863% |
| Q3 2025 | $65.4M | +264% |
| Q2 2025 | $11.6M | +365% |
| Q1 2025 | $70.2M | +$88.3M |
| Q4 2024 | $8.8M | -59% |
MYRG has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
MYRG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -10K shares |
| 1 year | +0.6% | +90K shares |
| 3 years | -6.6% | -1.1M shares |
| 5 years | -8.4% | -1.4M shares |
| Available history | -5.9% | -978K shares |
MYRG has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.3M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $75M |
| Q4 2024 | — |
MYRG has spent almost nothing on buybacks in the past year.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
MYRG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.6x | Very low |
MYRG's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MYRG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.4 | Neutral |
| Stochastic | 27.3 | Neutral |
MYRG's weekly RSI is 42 (neutral) and its Stochastic is 27 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
MYRG PE vs Industrials Sector
| Metric | MYRG | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 24x | 6% below |
| PE % | 44 | 58 | 14 pts below |
MYRG is trading at 23x earnings, in line with the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
MYRG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $283.5 | 1.8% below |
| 20 week MA | $317.9 | 12% below |
| 50 week MA | $319.0 | 13% below |
| 100 week MA | $242.7 | 15% above |
| 200 week MA | $188.7 | 48% above |
MYRG has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 48% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over MYRG on trend strength, trading above more of its moving averages.
MYRG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.1 | $60.4 | +88% |
| 2021 | $60.4 | $106.9 | +77% |
| 2022 | $106.9 | $90.3 | -16% |
| 2023 | $90.3 | $144.6 | +60% |
| 2024 | $144.6 | $150.1 | +3.8% |
| 2025 | $150.1 | $225.1 | +50% |
| 2026 YTD | $225.1 | $278.4 | +24% |
MYRG has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.